Corcept Therapeutics Says Trial of Lifyorli Combination Slows Ovarian Cancer Growth

MT newswire2026/10/26 13:19

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

09:19 AM EDT, 10/26/2026 (MT Newswires) -- Corcept Therapeutics (CORT) said Monday that results from a mid-stage trial evaluating the combination of Lifyorli with nab-paclitaxel and bevacizumab showed the treatment slowed ovarian cancer progression and shrank tumors in patients. The pharmaceutical company said the study demonstrated a median progression-free survival of 7.2 months and an objective response rate of 59% in 95 patients with platinum-resistant ovarian cancer. Patients whose tumors return or resume growing less than six months after receiving platinum-containing therapy are deemed "platinum-resistant," Corcept said. Shares of Corcept were up 2.5% in recent Thursday premarket activity.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

According to reports, the trading firm JonesTrading is marketing up to $500 million worth of stock shares on behalf of some investors, at a 3% to 5% premium over the IPO issue price. This indicates that investors are already transferring their anticipated IPO allotted shares before the IPO is officially issued.

华尔街见闻•2026/11/10 23:03

Nvidia continues to plummet, losing $430 billion in market value over two days, with Microsoft temporarily reclaiming the world's second place.

On Tuesday, Nvidia closed down 5.5%, a decline significantly greater than other major tech stocks, making it a key factor dragging down the tech sector's performance. During intraday trading on Tuesday, Microsoft's market capitalization briefly surpassed Nvidia, making it the world's second largest publicly traded company by market value. However, after Anthropic released its office suite, Microsoft's losses widened, causing it to fall behind Nvidia once again.

华尔街见闻•2026/11/10 23:01